# Perioperative Inflammation and Breast Cancer Outcome

> **NCT02141139** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1568 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** NSAIDS (ketorolac and ibuprofen)

## Key facts

- **NCT ID:** NCT02141139
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 1568 (ESTIMATED)
- **Last updated:** 2014-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141139, "Perioperative Inflammation and Breast Cancer Outcome". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT02141139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*